North Michael's most recent trade in Amedisys Inc. was a trade of 8,277 Common Stock done . Disclosure was reported to the exchange on Feb. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amedisys Inc | North Michael | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 8,277 | 23,932 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc | Michael North | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.69 per share. | 16 Feb 2024 | 1,591 | 22,341 (0%) | 0% | 93.7 | 149,061 | Common Stock |
| Amedisys Inc | Michael North | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 86.43 per share. | 03 Mar 2023 | 5,908 | 4,164 (0%) | 0% | 86.4 | 510,628 | Common Stock |
| Amedisys Inc | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 4,314 | 4,314 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 4,087 | 4,087 | - | - | Restricted Stock Unit (Performance-Based Vesting) | |
| Amedisys Inc | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,044 | 10,072 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc | Michael North | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.16 per share. | 20 Feb 2023 | 1,302 | 8,028 (0%) | 0% | 97.2 | 126,502 | Common Stock |
| Amedisys Inc | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 3,060 | 3,060 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 2,618 | 2,618 | - | - | Restricted Share Units (Performance-Based Vesting) | |
| Amedisys Inc | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 1,309 | 10,341 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc | Michael North | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.07 per share. | 17 Feb 2022 | 1,156 | 9,185 (0%) | 0% | 141.1 | 163,077 | Common Stock |